COMMUNIQUÉ DE PRESSE publié le 06/06/2024 à 13:00, il y a 5 mois 15 jours Theralase(R) Successfully Destroys Lung Cancer Theralase® Technologies Inc. announces preclinical success with Rutherrin® compound in targeting Non-Small Cell Lung Cancer. Results show improved tumour destruction and slower progression Theralase Technologies Inc. Cancer Treatment Preclinical Study NSCLC Rutherrin Compound
BRÈVE publiée le 04/06/2024 à 13:05, il y a 5 mois 17 jours Technologie Theralase® efficace pour l'inactivation des virus Theralase Ruvidar Recherche Antivirale Heliyon Inactivation Des Virus
BRÈVE publiée le 04/06/2024 à 13:05, il y a 5 mois 17 jours Theralase® Technology Effective in Virus Inactivation Theralase Ruvidar Antiviral Research Virus Inactivation Heliyon
COMMUNIQUÉ DE PRESSE publié le 04/06/2024 à 13:00, il y a 5 mois 17 jours Theralase(R) Technology Effective in Virus Inactivation Theralase Technologies Inc. announces successful inactivation of various viruses with lead compound RuvidarTM through peer-reviewed research. Potential for viral vaccine development highlighted Theralase Technologies Inc. RuvidarTM Peer-Reviewed Research Viral Inactivation Viral Vaccine Development
BRÈVE publiée le 30/05/2024 à 13:05, il y a 5 mois 22 jours Theralase publie ses états financiers du 1T2024 Résultats Financiers Traitement Du Cancer Theralase Étude II PDC
BRÈVE publiée le 30/05/2024 à 13:05, il y a 5 mois 22 jours Theralase Releases 1Q2024 Financial Statements Financial Results Cancer Treatment Theralase Study II PDCs
COMMUNIQUÉ DE PRESSE publié le 30/05/2024 à 13:00, il y a 5 mois 22 jours Theralase(R) Release's 1Q2024 Financial Statements Theralase® releases unaudited interim consolidated 1Q2024 financial statements. Company to host conference call on June 6th, 2024. Study II update and Break Through Designation progress discussed Conference Call Financial Statements Break Through Designation Theralase Study II
BRÈVE publiée le 24/04/2024 à 13:05, il y a 6 mois 27 jours Theralase Technologies Inc. Completes $750,200 Funding Round Private Placement Pharmaceuticals Clinical Research Investment Theralase Technologies
BRÈVE publiée le 24/04/2024 à 13:05, il y a 6 mois 27 jours Theralase Technologies Inc. finalise une ronde de financement de 750 200 $ Investissement Placement Privé Médicaments Recherche Clinique Technologies Théralase
COMMUNIQUÉ DE PRESSE publié le 24/04/2024 à 13:00, il y a 6 mois 27 jours Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement Theralase Technologies Inc. successfully closes Non-Brokered Private Placement offering, raising $CAN 750,200 for research and development of cancer treatments Private Placement Theralase Technologies Inc. Research And Development Stock Offering Cancer Treatments
Publié le 21/11/2024 à 06:58, il y a 1 jour 4 heures Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 1 jour 4 heures Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 1 jour 4 heures Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 1 jour 15 heures Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 1 jour 16 heures Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Publié le 22/11/2024 à 09:00, il y a 2 heures 22 minutes Industrial Software Company mlean Celebrates 10 Years of Continuous Improvement
Publié le 22/11/2024 à 00:00, il y a 11 heures 22 minutes Gratomic Announces Company and Operational Update
Publié le 21/11/2024 à 22:05, il y a 13 heures 17 minutes Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Publié le 21/11/2024 à 21:50, il y a 13 heures 32 minutes Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Publié le 21/11/2024 à 20:15, il y a 15 heures 7 minutes Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Publié le 22/11/2024 à 11:06, il y a 15 minutes Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
Publié le 22/11/2024 à 10:46, il y a 35 minutes Original-Research: ad pepper media International N.V. (von First Berlin Equity Research GmbH): Buy
Publié le 22/11/2024 à 09:45, il y a 1 heure 36 minutes The GSMA – China Unicom Open Gateway Global Use Case Innovation Challenge has begun!
Publié le 22/11/2024 à 09:23, il y a 1 heure 58 minutes Turkiye Garanti Bankasi A.S.: Announcement regarding issuance of subordinated notes
